Jacobs & Co
- SEC CIK
- 0001055544
- Latest filing
- Jul 8, 2026
REGN holding history
Regeneron Pharmaceuticals, Inc. in every 13F filed by Jacobs & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
REGN overviewAll 13F holders of REGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 10,372
- Value
- $6.47M
- % of portfolio
- 0.6%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 10,372 | $6.47M | 0.6% | +95+0.9% | Added | Holders |
| Q1 2026 | 10,277 | $7.94M | 0.8% | −49−0.5% | Reduced | Holders |
| Q4 2025 | 10,326 | $7.97M | 0.8% | +164+1.6% | Added | Holders |
| Q3 2025 | 10,162 | $5.71M | 0.5% | −132−1.3% | Reduced | Holders |
| Q2 2025 | 10,294 | $5.40M | 0.5% | +244+2.4% | Added | Holders |
| Q1 2025 | 10,050 | $6.37M | 0.7% | +859+9.3% | Added | Holders |
| Q4 2024 | 9,191 | $6.55M | 0.7% | +64+0.7% | Added | Holders |
| Q3 2024 | 9,127 | $9.59M | 1.0% | −290−3.1% | Reduced | Holders |
| Q2 2024 | 9,417 | $9.90M | 1.0% | −59−0.6% | Reduced | Holders |
| Q1 2024 | 9,476 | $9.12M | 1.0% | −45−0.5% | Reduced | Holders |
| Q4 2023 | 9,521 | $8.36M | 0.9% | −161−1.7% | Reduced | Holders |
| Q3 2023 | 9,682 | $7.97M | 1.0% | −270−2.7% | Reduced | Holders |
| Q2 2023 | 9,952 | $7.15M | 0.9% | −295−2.9% | Reduced | Holders |
| Q1 2023 | 10,247 | $8.42M | 1.0% | −1,019−9.0% | Reduced | Holders |
| Q4 2022 | 11,266 | $8.13M | 1.1% | −416−3.6% | Reduced | Holders |
| Q3 2022 | 11,682 | $8.05M | 1.2% | +108+0.9% | Added | Holders |
| Q2 2022 | 11,574 | $6.84M | 0.9% | −697−5.7% | Reduced | Holders |
| Q1 2022 | 12,271 | $8.57M | 0.9% | −419−3.3% | Reduced | Holders |
| Q4 2021 | 12,690 | $8.01M | 0.8% | +341+2.8% | Added | Holders |
| Q3 2021 | 12,349 | $7.47M | 0.9% | +169+1.4% | Added | Holders |
| Q2 2021 | 12,180 | $6.80M | 0.8% | +145+1.2% | Added | Holders |
| Q1 2021 | 12,035 | $5.69M | 0.7% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.